|Articles|December 1, 1997

December 1997
Volume 3
Issue 12

Sedating Effects of AM/PM Antihistamine Dosing with Evening Chlorpheniramine and Morning Terfenadine

Author(s)Gary G. Kay, PhD, Kenneth E. Plotkin, MD, Mary Beth Quig, PhD

Download PDF: Sedating Effects of AM/PM Antihistamine Dosing with Evening Chlorpheniramine and Morning Terfenadine

Articles in this issue

over 28 years ago

Article

Cost Implications of Selective Preoperative Screening in the Care of Candidates for Peripheral Vascular Operations

over 28 years ago

Article

Disease Management Interventions to Improve Outcomes in Congestive Heart Failure

over 28 years ago

Article

Physicians in Training as Quality Managers: Survival Strategy for Academic Health Centers

over 28 years ago

Article

Gastrointestinal Illness in Managed Care: Healthcare Utilization and Costs

over 28 years ago

Article

Recognition and Treatment of Patients in the Persistent Vegetative State

over 28 years ago

Article

Adverse Drug Reactions: A Review for Healthcare Practitioners

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Sedating Effects of AM/PM Antihistamine Dosing with Evening Chlorpheniramine and Morning Terfenadine

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week

Clesrovimab Demonstrates Safety Through a Second RSV Season in High-Risk Infants

Dry Eye Disease Is More Than "Dry Eyes": Experts Explain the 2 Types

Multidisciplinary Teams Improve Biomarker Testing and Lung Cancer Care: Urs Weber, MD

FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis